PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30140092-0	2018	Study Design of a Phase II Clinical Trial to Assess the Efficacy and Safety of Eperisone in Japanese Type 2 Diabetes Patients with Risk and Non-risk Alleles of CDKAL1.	eperisone	79-88	CDK5 regulatory subunit associated protein 1 like 1	Homo sapiens	160-166	
30140092-4	2018	We have launched a phase II clinical study to investigate the potential anti-diabetic effect of eperisone in T2D patients carrying risk or non-risk alleles of CDKAL1.	eperisone	96-105	CDK5 regulatory subunit associated protein 1 like 1	Homo sapiens	159-165	
30140092-6	2018	We also examined whether the efficacy of eperisone in T2D patients is associated with CDKAL1 activity.	eperisone	41-50	CDK5 regulatory subunit associated protein 1 like 1	Homo sapiens	86-92